Offerings // Ping An Biomedical Co., Ltd.

PASW offering history

Every offering-related filing in Ping An Biomedical Co., Ltd.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 110 filings back to Dec 21, 2021.

Last executed offering
Jul 21, 2025
424B4 — priced deal (shares or notes)
Last registration (announced)
Oct 23, 2026
F-3 — capacity, not a sale
Executed, last 12 months
0
424B pricings + 8-K 3.02 sales
Registered, last 12 months
2
S-1/S-3/F-series registrations
DateFilingWhat it means
Oct 23, 2026F-3 →REGISTEREDF-3 registration — capacity to sell shares, not a sale yet
Feb 26, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 13, 2026F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Jul 21, 2025424B4 →EXECUTEDFinal prospectus — offering priced (typical for IPOs and marketed share deals)
Jul 21, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jul 11, 2025FWP →MARKETINGFree-writing prospectus — offering being marketed
Jun 30, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 26, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Apr 14, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Mar 25, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Mar 18, 2025FWP →MARKETINGFree-writing prospectus — offering being marketed
Mar 17, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Jan 24, 2025F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Nov 4, 2024F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Oct 23, 2024F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Oct 4, 2024RW →WITHDRAWNRegistration withdrawn
Oct 4, 2024F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
Jun 28, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jun 18, 2024F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Feb 20, 2024FWP →MARKETINGFree-writing prospectus — offering being marketed
Jan 10, 2024F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Nov 16, 2023F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Oct 31, 2023F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Oct 20, 2023F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Sep 18, 2023F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
May 16, 2023F-1/A →REGISTEREDF-1/A registration — capacity to sell shares, not a sale yet
Apr 28, 2023F-1 →REGISTEREDF-1 registration — capacity to sell shares, not a sale yet
PASW offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full PASW workspace →
PASW offering FAQ

When did PASW last execute an offering?

Per SEC filings, Ping An Biomedical Co., Ltd.'s most recent priced offering document is a 424B4 filed 2025-07-21. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did PASW last announce or register an offering?

The most recent registration is a F-3 filed 2026-10-23. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.